Docoh
Loading...

MRSN Mersana Therapeutics

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On June 11, 2021, Mersana Therapeutics, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”), at which a quorum was present. At the Annual Meeting, the stockholders of the Company voted on four proposals as follows: (i) to elect Willard Dere, M.D., and Martin Huber, M.D., each as a Class I member of the board of directors to serve until the Company’s 2024 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal (“Proposal 1”); (ii) to ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (“Proposal 2”); (iii) to approve, on an advisory basis, the compensation of the Company’s named executive officers (“Proposal 3”); and (iv) to approve, on an advisory basis, the holding of an annual say-on-pay vote on executive compensation (“Proposal 4”).

The Company’s stockholders approved Proposal 1. The votes cast at the Annual Meeting were as follows:

NomineeVotes ForWithheldBroker Non-Votes
Willard Dere, M.D.47,965,08811,208,4503,408,118
Martin Huber, M.D.48,339,07910,834,4593,408,118


The Company’s stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows:

Votes ForVotes AgainstAbstain
62,433,551141,3636,742


The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows:

Votes ForVotes AgainstAbstain
56,298,4032,858,42316,712


The Company’s stockholders approved Proposal 4. The votes cast at the Annual Meeting were as follows:

1 Year2 Years3 YearsAbstain
58,987,861756172,53312,388